Analyst Ratings for NervGen Pharma Corp (NGEN)
NGEN Rating Summary
NGEN Price Target Summary
- Highest: $18.00 (Lucid Capital Markets)
- Lowest: $10.00 (Leerink)
- Average: $13.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.75 (+723.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$13.75 (+723.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Leerink | Marc Goodman | New Coverage | Outperform (N/A) |
10.00 (N/A) |
1.88 (1.67) |
-11.17% | Details |
| 6/11/2026 | TD Cowen | Joseph Thome | New Coverage | Buy (N/A) |
N/A (N/A) |
1.73 (1.67) |
-3.47% | Details |
 |
||||||||
|
||||||||
